National Institute of Health, South Korea
In obesity induced by high-fat diets, low-dose genistein raised mitochondrial enzyme activities
Published in Pharma Investments, Ventures and Law Weekly, November 5th, 2006
"Genistein has been suggested to prevent insulin resistance and its related diseases. We investigated the effects of dietary genistein at different levels on hepatic lipid levels and mitochondrial functions in mice fed high-fat diets. C57BL/6J mice were randomly divided into four groups and fed a high-fat diet containing genistein at levels of 0, 0.1, 0.2, and 0.4% (HF, HF + 0.1G, HF + 0.2G, and HF + 0.4G) for 12 wk," investigators in South Korea report.
Y.M. Lee and colleagues working with the National Institute of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- Accentia Biopharmaceuticals
Accentia enters into definitive deal for a $25 million financing - Acorda Therapeutics
Acorda Therapeutics announces $31.5 million financing - Affinergy
Affinergy awarded $1.8 million grant for implant coatings - Aida Pharmaceuticals
Aida Pharmaceuticals' trial genetic cancer treatment awarded prize in China - Arrow International
Arrow International reports 13% increase in sales - Auriga Laboratories
Auriga reports revenue guidance forecast of $26.4 million - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
